Kim Dong 4
4 · UroGen Pharma Ltd. · Filed Mar 29, 2022
Insider Transaction Report
Form 4
Kim Dong
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-25+30,000→ 30,000 totalExercise: $8.61Exp: 2032-03-24→ Ordinary Shares (30,000 underlying)
Footnotes (1)
- [F1]One third of the shares underlying the stock option will vest on each of March 25, 2023, March 25, 2024 and March 25, 2025.